Study S003219

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

ClinicalTrials.gov record

Registration

Registration: NCT07497880
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 306
Start: 2026-04-06
Primary completion: 2027-07-07
Lead sponsor: Kailera
Conditions: Obesity; Overweight
Interventions: DRUG:KAI-7535; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percent Change from Baseline in Body Weight at Week 44 for Participants Without Diabetes Mellitus [Baseline, Week 44]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.